Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Magerl

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 12, 2020
Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countriesVolker Wahn, Werner Aberer, Emel Aygören-Pürsün, et al.
Clinical Reviews in Allergy & Immunology|November 7, 2024
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic ReviewHilary J Longhurst, Mauro Cancian, Vesna Grivcheva-Panovska, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema ControlKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 16, 2025
Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacksH Henry Li, Emel Aygören-Pürsün, Markus Magerl, et al.
Allergy|December 10, 2019
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedemaKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2026
Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical OutcomesMarc A Riedl, Danny M Cohn, Markus Magerl, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 22, 2020
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiencySofia Vatsiou, Maria Zamanakou, Gedeon Loules, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2014
Hereditary angioedema: molecular and clinical differences among European populationsMatthaios Speletas, Agnes Szilagyi, Fotis Psarros, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 12, 2020
Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countriesVolker Wahn, Werner Aberer, Emel Aygören-Pürsün, et al.
Clinical Reviews in Allergy & Immunology|November 7, 2024
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic ReviewHilary J Longhurst, Mauro Cancian, Vesna Grivcheva-Panovska, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema ControlKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 16, 2025
Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacksH Henry Li, Emel Aygören-Pürsün, Markus Magerl, et al.
Allergy|December 10, 2019
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedemaKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2026
Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical OutcomesMarc A Riedl, Danny M Cohn, Markus Magerl, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 22, 2020
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiencySofia Vatsiou, Maria Zamanakou, Gedeon Loules, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2014
Hereditary angioedema: molecular and clinical differences among European populationsMatthaios Speletas, Agnes Szilagyi, Fotis Psarros, et al.
Pageof 16